These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 29776833

  • 1. Novel oxazolxanthone derivatives as a new type of α-glucosidase inhibitor: synthesis, activities, inhibitory modes and synergetic effect.
    Ding SM, Lan T, Ye GJ, Huang JJ, Hu Y, Zhu YR, Wang B.
    Bioorg Med Chem; 2018 Jul 23; 26(12):3370-3378. PubMed ID: 29776833
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Synthesis of 3-acyloxyxanthone derivatives as α-glucosidase inhibitors: A further insight into the 3-substituents' effect.
    Li GL, Cai CY, He JY, Rao L, Ma L, Liu Y, Wang B.
    Bioorg Med Chem; 2016 Apr 01; 24(7):1431-8. PubMed ID: 26917220
    [Abstract] [Full Text] [Related]

  • 4. Synthesis of Bis-indolylmethane sulfonohydrazides derivatives as potent α-Glucosidase inhibitors.
    Gollapalli M, Taha M, Ullah H, Nawaz M, AlMuqarrabun LMR, Rahim F, Qureshi F, Mosaddik A, Ahmat N, Khan KM.
    Bioorg Chem; 2018 Oct 01; 80():112-120. PubMed ID: 29894890
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Design and synthesis of novel pyrazole-phenyl semicarbazone derivatives as potential α-glucosidase inhibitor: Kinetics and molecular dynamics simulation study.
    Azimi F, Ghasemi JB, Azizian H, Najafi M, Faramarzi MA, Saghaei L, Sadeghi-Aliabadi H, Larijani B, Hassanzadeh F, Mahdavi M.
    Int J Biol Macromol; 2021 Jan 01; 166():1082-1095. PubMed ID: 33157144
    [Abstract] [Full Text] [Related]

  • 9. Design, synthesis, docking study, α-glucosidase inhibition, and cytotoxic activities of acridine linked to thioacetamides as novel agents in treatment of type 2 diabetes.
    Mohammadi-Khanaposhtani M, Rezaei S, Khalifeh R, Imanparast S, Faramarzi MA, Bahadorikhalili S, Safavi M, Bandarian F, Nasli Esfahani E, Mahdavi M, Larijani B.
    Bioorg Chem; 2018 Oct 01; 80():288-295. PubMed ID: 29980114
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and biological evaluation of coumarin derivatives as α-glucosidase inhibitors.
    Xu XT, Deng XY, Chen J, Liang QM, Zhang K, Li DL, Wu PP, Zheng X, Zhou RP, Jiang ZY, Ma AJ, Chen WH, Wang SH.
    Eur J Med Chem; 2020 Mar 01; 189():112013. PubMed ID: 31972390
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Oxindole based oxadiazole hybrid analogs: Novel α-glucosidase inhibitors.
    Taha M, Imran S, Rahim F, Wadood A, Khan KM.
    Bioorg Chem; 2018 Feb 01; 76():273-280. PubMed ID: 29223804
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Binding mechanism and synergetic effects of xanthone derivatives as noncompetitive α-glucosidase inhibitors: a theoretical and experimental study.
    Liu Y, Ma L, Chen WH, Park H, Ke Z, Wang B.
    J Phys Chem B; 2013 Oct 31; 117(43):13464-71. PubMed ID: 24083955
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Synthesis and biological evaluation of novel 1,2,4-triazine derivatives bearing carbazole moiety as potent α-glucosidase inhibitors.
    Wang G, Wang J, He D, Li X, Li J, Peng Z.
    Bioorg Med Chem Lett; 2016 Jun 15; 26(12):2806-2809. PubMed ID: 27177827
    [Abstract] [Full Text] [Related]

  • 19. Synthesis, in vitro inhibitory activity, kinetic study and molecular docking of novel N-alkyl-deoxynojirimycin derivatives as potential α-glucosidase inhibitors.
    Lin P, Zeng JC, Chen JG, Nie XL, Yuan E, Wang XQ, Peng DY, Yin ZP.
    J Enzyme Inhib Med Chem; 2020 Dec 15; 35(1):1879-1890. PubMed ID: 33003963
    [Abstract] [Full Text] [Related]

  • 20. Novel Coumarin Containing Dithiocarbamate Derivatives as Potent α-Glucosidase Inhibitors for Management of Type 2 Diabetes.
    Mollazadeh M, Mohammadi-Khanaposhtani M, Valizadeh Y, Zonouzi A, Faramarzi MA, Kiani M, Biglar M, Larijani B, Hamedifar H, Mahdavi M, Hajimiri MH.
    Med Chem; 2021 Dec 15; 17(3):264-272. PubMed ID: 32851964
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.